HOME >> MEDICINE >> NEWS
Controversial drug shown to act on brain protein to cut alcohol use

A naturally occurring hallucinogen advocated by some clinicians as a potent anti-addiction drug has been rigorously studied for the first time, confirming its ability to block alcohol craving in rodents, and clarifying how it works in the brain. The new research findings about the drug Ibogaine open the way for development of other drugs to reverse addiction without Ibogaine's side effects, potentially adding to the small arsenal of drugs that effectively combat addiction.

Derived from a West African shrub, Ibogaine has been championed for years by a cadre of clinicians and drug treatment advocates impressed with its ability to reverse withdrawal symptoms and craving for alcohol and various drugs of abuse. It has been used outside of the U.S. to treat addiction by American and other clinicians. But its side effects, including hallucinations, which made it popular in the 1960s drug culture, and evidence of toxicity to certain nerve cells in rodent studies have discouraged careful studies of its clinical potential against drug and alcohol addiction. The FDA has not approved use of Ibogaine in the U.S.

Scientists at UCSF's Ernest Gallo Clinic and Research Center have now shown definitively in experiments with mice and rats that Ibogaine does reduce alcohol consumption, and they have determined that it does so by increasing the level of a brain protein known as glial cell line-derived neurotrophic factor, or GDNF. In a separate study, they demonstrated that GDNF by itself decreases alcohol consumption.

The research is being published in the January 19 issue of The Journal of Neuroscience.

"By identifying the brain protein that Ibogaine regulates to reduce alcohol consumption in rats, we have established a link between GDNF and reversal of addiction -- knowledge of a molecular mechanism that should allow development of a new class of drugs to treat addiction without Ibogaine's side effects," said Dorit Ron, PhD, UCSF associate professor of
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
18-Jan-2005


Page: 1 2 3

Related medicine news :

1. Controversial Atkins Diet may be beneficial for people with epilepsy
2. Controversial performance enhancer "andro" affects brains as well as brawn, say UMass researchers
3. Cartilage repair techniques shown to restore patient mobility and reduce pain
4. Sprinklers shown effective in slowing dorm fires
5. HPV vaccine shown effective at reducing cancer-causing infections
6. HPV vaccine shown to substantially reduce cervical cancer
7. New research results: Heart jacket shown to be effective
8. Pioglitazone shown to reverse thickening of carotid artery wall
9. Isolated soy protein shown to benefit type 2 diabetics, study indicates
10. Pioglitazone HCI shown to lower blood pressure in hypertensive patients with type 2 diabetes
11. Increased risk of cardiovascular disease shown in PCOS patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... , ... September 11, 2019 , ... Autopsies don’t lie. ... or injury to the body. , Methamphetamine permanently harms the heart. It increases ... are getting a better understanding of how the damage occurs. , An ...
(Date:9/11/2019)... BAR, Calif. (PRWEB) , ... September 11, 2019 , ... ... Ahimi. This plant-based poke bowl option appeals to vegans, vegetarians, pescatarians and poke ... soy sauce, sugar, and sesame oil. With its meaty texture similar to tuna, ...
(Date:9/11/2019)... ... 10, 2019 , ... Women’s Excellence is excited to announce the opening of ... Ave, Suite 103, Royal Oak, MI 48073 in the heart of Royal Oak off ... health services in a contemporary, spa-like atmosphere. We are thrilled to be in ...
(Date:9/11/2019)... , ... September 10, 2019 , ... ... Doctors by Pasadena Magazine. These physicians have been recognized among the best doctors ... pediatric subspecialties:, Robert H. Cho, M.D. – Chief ...
(Date:9/11/2019)... ... September 10, 2019 , ... Episcopal Relief & ... vulnerable communities impacted by Hurricane Dorian. , In partnership with the Episcopal ... of Georgia, and the Episcopal Farmworker Ministry, Episcopal Relief & Development is giving ...
Breaking Medicine News(10 mins):
(Date:9/18/2019)... ... September 18, 2019 , ... ... other healthcare-focused subsidiaries, today announced the acquisition of Kynectiv, Inc . ... professionals (HCPs) to make decisions to achieve optimal patient outcomes. Feedback and ...
(Date:9/18/2019)... ... 18, 2019 , ... U.S. Dermatology Partners was a proud sponsor ... September 14th. The event took place at Lake Ray Hubbard in Rockwall. Over ... The money raised helps fund phase 1 clinical trials for cancer research ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... proud to establish a new partnership with NextGen Healthcare Inc., a leading healthcare ... of partners, which include Nextech, DrChrono, Symplast and Azalea, with additional partnerships to ...
Breaking Medicine Technology:
Cached News: